1. Post-marketing experience with belimumab in U.S. Lupus Centers: data from the Lupus Clinical Trials Consortium, Inc. (LCTC) National Patient Registry;Yazdany;Arthritis Rheum,2013
2. Favorable clinical response to belimumab at three months;Askanase;Arthritis Rheum,2013
3. 12-month outcomes associated With Belimumab in patients with systemic lupus erythematosus in clinical practice settings: the observe study;Collins;Arthritis Rheum,2013
4. The 1982 revised criteria for the classification of systemic lupus erythematosus;Tan;Arthritis Rheum,1982
5. Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort;Urowitz;Arthritis Care Res (Hoboken),2012